DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Nielsen OS, Dombernowsky P, Mouridsen H. et al.
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
Br J Cancer 1998; 78: 1634-1639
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.